Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Orange › NPI 1558575746
Hospital

ST. Joseph Hospital of Orange

ST. Joseph Hospital of Orange was paid $65.95M by Medicaid between Jan 2018 and Dec 2024, across 496 billing codes. Its largest line is 90999, dialysis (unlisted procedure) — 21% of everything it billed.

33Billing provider infoST. JOSEPH HOSPITAL OF ORANGE
ORANGE, CA 92868
33aNPI1558575746assigned 05/09/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$65.95M
24GClaims2,357,821
24DCodes billed496
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#42 of 410
Median peer was paid$6.90M
This provider vs. median9.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018312,906$8.43M
2019333,868$10.64M
2020376,910$10.94M
2021372,294$8.43M
2022364,191$8.53M
2023355,668$9.77M
2024incomplete241,984$9.21M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
90999 Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient 21% 57,838 4,006 $14.13M
78815 Positron emission tomography (PET) for limited area imaging 6.7% 2,724 2,591 $4.42M
J9306 Injection, pertuzumab, 1 mg 3.8% 847 569 $2.49M
0450 Emergency room services 3.2% 131,678 113,327 $2.10M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.1% 44,361 36,732 $2.03M
J0897 Injection, denosumab, 1 mg 2.8% 2,188 1,829 $1.87M
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg 2.8% 1,076 680 $1.83M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.4% 8,315 7,566 $1.59M
96375 Therapeutic injection; each additional sequential IV push 2.2% 44,660 30,957 $1.43M
Z7502 1.9% 33,674 33,390 $1.27M
A0429 Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) 1.7% 25,672 15,661 $1.13M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.6% 33,509 7,109 $1.05M
484 more codes
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 1.4% 11,543 $902K
J2505 Injection, pegfilgrastim, 6 mg 1.3% 547 $860K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 1.1% 15,692 $749K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 1.1% 2,678 $713K
J0882 Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) 1.0% 4,892 $684K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.0% 42,870 $678K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 6,549 $652K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 110,217 $641K
Q5114 Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg <1% 818 $621K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 11,686 $603K
80053 Comprehensive metabolic panel <1% 65,737 $593K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 28,844 $586K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 6,266 $579K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 7,996 $570K
70450 Computed tomography, head or brain; without contrast material <1% 9,064 $563K
93975 <1% 3,589 $558K
77067 Screening mammography, bilateral, including computer-aided detection <1% 4,685 $551K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 3,097 $547K
96361 Intravenous infusion, hydration; each additional hour <1% 17,098 $526K
J3490 Unclassified drugs <1% 97,481 $522K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 8,412 $483K
P9016 Red blood cells, leukocytes reduced, each unit <1% 2,135 $471K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 10,261 $463K
59025 Fetal non-stress test <1% 20,283 $444K
99199 Unlisted special service, procedure or report <1% 7,051 $414K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,506 $356K
Q4081 Injection, epoetin alfa, 100 units (for esrd on dialysis) <1% 27,719 $343K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 2,247 $342K
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg <1% 349 $337K
76830 Ultrasound, transvaginal <1% 5,978 $332K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,802 $316K
97750 <1% 5,210 $312K
76801 <1% 5,872 $312K
Z9725 <1% 7,160 $308K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 6,729 $294K
G0378 Hospital observation service, per hour <1% 1,331 $289K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 10,314 $288K
71045 Radiologic examination, chest; single view <1% 28,415 $264K
80048 Basic metabolic panel (calcium, ionized) <1% 54,494 $257K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 4,927 $251K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 5,661 $248K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 5,562 $240K
0760 <1% 18,228 $239K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 6,629 $227K
93971 <1% 2,045 $203K
77066 Tomosynthesis, mammo <1% 1,550 $201K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 5,023 $189K
83690 <1% 36,397 $182K
84484 <1% 25,457 $174K
97139 <1% 8,239 $173K
77334 <1% 1,019 $172K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,935 $172K
96417 <1% 4,215 $170K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 3,667 $166K
99285 Emergency room visit (most serious) <1% 6,092 $164K
77412 <1% 3,510 $163K
87631 <1% 3,242 $160K
83880 <1% 7,381 $158K
J2997 Injection, alteplase recombinant, 1 mg <1% 4,496 $157K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 14,656 $137K
77063 Screening digital breast tomosynthesis, bilateral <1% 4,670 $137K
93325 <1% 1,105 $133K
76642 <1% 2,275 $133K
J1756 Injection, iron sucrose, 1 mg <1% 7,550 $130K
J9271 Injection, pembrolizumab, 1 mg <1% 29 $117K
96367 <1% 3,737 $116K
99283 Emergency room visit (moderate) <1% 7,263 $111K
77336 <1% 2,092 $111K
77065 Tomosynthesis, mammo <1% 1,183 $109K
77386 <1% 448 $106K
71046 Radiologic examination, chest; 2 views <1% 6,505 $103K
76770 <1% 1,771 $100K
83970 <1% 2,759 $97K
C1769 Guide wire <1% 2,610 $95K
J2501 Injection, paricalcitol, 1 mcg <1% 29,746 $89K
96376 <1% 17,914 $86K
84443 Thyroid stimulating hormone (TSH) <1% 7,344 $86K
80061 Lipid panel <1% 7,331 $86K
J1453 Injection, fosaprepitant, 1 mg <1% 1,754 $85K
87086 Culture, bacterial; quantitative colony count, urine <1% 16,038 $84K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 5,790 $82K
81001 <1% 37,034 $82K
Q5120 Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg <1% 104 $81K
84702 <1% 18,190 $78K
J2469 Injection, palonosetron hcl, 25 mcg <1% 4,658 $77K
85027 <1% 15,528 $75K
J1170 Injection, hydromorphone, up to 4 mg <1% 28,382 $75K
J1644 Injection, heparin sodium, per 1000 units <1% 31,915 $74K
90715 <1% 2,605 $74K
87040 <1% 10,038 $74K
80076 <1% 18,393 $73K
96415 <1% 2,311 $73K
83036 Hemoglobin; glycosylated (A1C) <1% 8,652 $70K
36902 <1% 132 $68K
82330 <1% 7,788 $68K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 37,884 $68K
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg <1% 98 $67K
71250 <1% 768 $64K
73562 <1% 3,446 $64K
73630 <1% 3,232 $59K
93970 <1% 309 $57K
82947 <1% 32,119 $55K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 506 $55K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,004 $55K
0160 <1% 6,702 $55K
A9585 Injection, gadobutrol, 0.1 ml <1% 3,201 $54K
82805 <1% 3,677 $53K
84145 <1% 3,073 $49K
76536 <1% 910 $49K
81025 <1% 15,967 $49K
86923 <1% 1,703 $48K
99284 Emergency room visit (serious) <1% 3,629 $48K
70551 Magnetic resonance imaging, brain; without contrast material <1% 416 $48K
81003 <1% 32,658 $46K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 1,033 $45K
95811 <1% 186 $43K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 808 $43K
73610 <1% 2,399 $42K
82803 <1% 3,869 $42K
72100 <1% 1,921 $41K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 1,431 $41K
73130 <1% 2,238 $40K
73030 <1% 2,326 $40K
97010 <1% 1,347 $40K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,912 $39K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,955 $39K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 137 $39K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,908 $39K
87077 <1% 6,070 $38K
Z7500 <1% 1,113 $38K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 9,097 $37K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 929 $37K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 263 $36K
77080 <1% 1,104 $35K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,986 $34K
J9070 Cyclophosphamide, 100 mg <1% 208 $34K
J0606 Injection, etelcalcetide, 0.1 mg <1% 764 $34K
J7030 Infusion, normal saline solution , 1000 cc <1% 5,263 $34K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 17,947 $32K
J0185 Injection, aprepitant, 1 mg <1% 265 $32K
83735 <1% 8,716 $31K
99153 Mod sedat endo service >5yrs <1% 1,145 $31K
87186 <1% 5,045 $30K
76813 <1% 378 $29K
J2270 Injection, morphine sulfate, up to 10 mg <1% 11,965 $29K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 12,425 $29K
93976 <1% 181 $28K
83550 <1% 4,050 $28K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 10,354 $27K
86141 <1% 3,467 $26K
Z6004 <1% 12 $26K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,097 $26K
77300 <1% 253 $26K
J2704 Injection, propofol, 10 mg <1% 7,217 $25K
36430 <1% 189 $25K
82728 <1% 3,588 $25K
J0690 Injection, cefazolin sodium, 500 mg <1% 6,767 $24K
85610 <1% 10,276 $24K
Z7610 <1% 5,982 $24K
74018 <1% 1,594 $24K
83540 <1% 4,235 $24K
86901 <1% 11,759 $24K
82375 <1% 3,606 $23K
83605 <1% 4,037 $23K
86803 <1% 1,717 $23K
76937 <1% 1,962 $23K
86900 <1% 11,766 $23K
88720 <1% 4,400 $23K
85379 <1% 3,229 $22K
87081 <1% 2,358 $22K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 11,958 $22K
82570 <1% 5,349 $22K
84100 <1% 7,348 $22K
97165 <1% 806 $21K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 10,095 $21K
99152 <1% 1,232 $21K
76819 Fetal biophysical profile; without non-stress testing <1% 382 $21K
72125 Computed tomography, cervical spine; without contrast material <1% 228 $21K
73110 <1% 1,117 $20K
73502 <1% 721 $19K
88307 <1% 438 $18K
85730 <1% 5,369 $18K
J7050 Infusion, normal saline solution, 250 cc <1% 4,200 $18K
96402 <1% 1,318 $17K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 285 $17K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg <1% 28 $17K
72040 <1% 667 $17K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 504 $16K
86850 <1% 7,526 $16K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 7,599 $16K
10060 <1% 1,182 $15K
J2060 Injection, lorazepam, 2 mg <1% 7,312 $15K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,398 $15K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,403 $15K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 3,493 $14K
84550 <1% 4,764 $14K
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility <1% 242 $14K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 689 $14K
97014 <1% 823 $14K
77280 <1% 181 $14K
83050 <1% 3,609 $13K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 335 $13K
A4217 Sterile water/saline, 500 ml <1% 2,185 $13K
90834 Psychotherapy session, about 45 minutes <1% 202 $13K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 3,062 $13K
J1815 Injection, insulin, per 5 units <1% 5,570 $13K
82043 <1% 2,444 $13K
J9171 Injection, docetaxel, 1 mg <1% 157 $12K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,413 $12K
87340 <1% 1,472 $11K
88304 <1% 1,638 $11K
96523 <1% 1,706 $11K
82550 <1% 3,237 $11K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 5,400 $11K
J3370 Injection, vancomycin hcl, 500 mg <1% 2,563 $11K
73590 <1% 672 $11K
0270 <1% 100,279 $11K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 6,141 $10K
80069 <1% 1,579 $10K
49083 <1% 286 $10K
77001 <1% 270 $10K
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,901 $10K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 28 $10K
77290 <1% 72 $9K
80197 <1% 1,678 $9K
J9045 Injection, carboplatin, 50 mg <1% 381 $9K
77295 <1% 31 $9K
84156 <1% 3,555 $9K
99401 <1% 524 $8K
84132 <1% 10,504 $8K
S0164 Injection, pantoprazole sodium, 40 mg <1% 1,774 $8K
97162 <1% 1,447 $8K
76870 <1% 200 $8K
73080 <1% 373 $8K
77417 <1% 711 $7K
47562 <1% 44 $7K
85007 <1% 4,612 $7K
76825 <1% 360 $7K
84703 <1% 4,185 $7K
87070 <1% 1,693 $7K
0360 <1% 3,101 $7K
83615 <1% 2,546 $7K
87210 <1% 1,991 $7K
84439 <1% 984 $7K
96411 <1% 373 $7K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,104 $7K
36415 Collection of venous blood by venipuncture <1% 6,744 $6K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 167 $6K
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 111 $6K
82731 <1% 328 $6K
96156 <1% 363 $6K
84460 <1% 1,379 $6K
82040 <1% 1,688 $5K
84295 <1% 7,319 $5K
84520 <1% 1,979 $5K
93880 <1% 39 $5K
87205 <1% 2,103 $5K
86920 <1% 282 $5K
0710 <1% 6,756 $5K
76820 <1% 660 $5K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,844 $5K
12001 <1% 434 $5K
85652 <1% 2,354 $5K
90686 <1% 209 $5K
82435 <1% 7,234 $5K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,262 $4K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 964 $4K
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 1,265 $4K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 17 $4K
87075 <1% 923 $4K
88342 <1% 437 $4K
70496 <1% 26 $4K
J7120 Ringers lactate infusion, up to 1000 cc <1% 586 $4K
10061 <1% 185 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 732 $4K
G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes <1% 54 $4K
0250 <1% 11,440 $4K
87799 <1% 265 $4K
77049 <1% 12 $4K
85018 <1% 7,936 $4K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 1,043 $3K
86706 <1% 381 $3K
J1940 Injection, furosemide, up to 20 mg <1% 1,646 $3K
G0202 Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed <1% 61 $3K
87147 <1% 1,168 $3K
82465 <1% 1,142 $3K
97802 <1% 56 $3K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,236 $3K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 26 $3K
70486 <1% 28 $3K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 3,455 $3K
84480 <1% 283 $3K
87430 <1% 636 $3K
99215 Doctor's office visit, returning patient (complex) <1% 32 $3K
97116 <1% 123 $2K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 87 $2K
93017 <1% 59 $2K
0761 <1% 5,259 $2K
82553 <1% 446 $2K
82140 <1% 262 $2K
96401 <1% 161 $2K
J9267 Injection, paclitaxel, 1 mg <1% 137 $2K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 13 $2K
71020 <1% 113 $2K
93320 <1% 52 $2K
H1003 Prenatal care, at-risk enhanced service; education <1% 66 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 429 $2K
J8540 Dexamethasone, oral, 0.25 mg <1% 2,292 $2K
82150 <1% 430 $2K
95806 <1% 33 $2K
J2720 Injection, protamine sulfate, per 10 mg <1% 500 $2K
74181 <1% 12 $2K
87493 <1% 89 $2K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 28 $2K
76827 <1% 126 $2K
90747 <1% 16 $2K
80047 <1% 296 $2K
87497 <1% 171 $2K
71010 <1% 176 $2K
G0204 Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral <1% 23 $2K
J1630 Injection, haloperidol, up to 5 mg <1% 3,043 $2K
73140 <1% 160 $2K
72141 <1% 13 $2K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 509 $2K
29125 <1% 463 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 666 $2K
41899 Unlisted procedure, dentoalveolar structures <1% 54 $2K
88341 <1% 26 $2K
85045 <1% 592 $1K
70498 <1% 14 $1K
29515 <1% 291 $1K
J3480 Injection, potassium chloride, per 2 meq <1% 859 $1K
C1760 Closure device, vascular (implantable/insertable) <1% 12 $1K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 231 $1K
J9190 Injection, fluorouracil, 500 mg <1% 135 $1K
0272 <1% 6,997 $1K
J0692 Injection, cefepime hydrochloride, 500 mg <1% 200 $1K
80179 <1% 65 $1K
C1893 Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away <1% 638 $1K
72170 <1% 163 $1K
90688 <1% 40 $1K
80143 <1% 61 $1K
G0206 Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral <1% 14 $1K
86902 <1% 70 $987.18
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 324 $986.90
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 269 $946.31
0258 <1% 7,473 $921.19
96368 <1% 82 $918.99
J1953 Injection, levetiracetam, 10 mg <1% 108 $853.70
J0640 Injection, leucovorin calcium, per 50 mg <1% 88 $829.14
73090 <1% 54 $822.11
92610 <1% 13 $815.84
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 9,541 $797.53
77331 <1% 27 $787.78
99499 <1% 15 $744.00
J2550 Injection, promethazine hcl, up to 50 mg <1% 212 $670.07
85014 <1% 377 $665.01
0637 <1% 3,371 $661.67
J0456 Injection, azithromycin, 500 mg <1% 318 $656.62
74022 <1% 42 $640.57
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,093 $633.98
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 13 $564.98
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 130 $551.19
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion <1% 19 $550.60
90656 <1% 22 $535.51
86140 <1% 173 $531.90
97803 <1% 40 $529.70
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 66 $499.73
84540 <1% 142 $480.44
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,923 $434.62
93350 <1% 12 $430.01
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 307 $412.64
82565 <1% 263 $381.96
93798 <1% 50 $355.08
82270 <1% 107 $347.70
84436 <1% 79 $344.83
C1789 Prosthesis, breast (implantable) <1% 12 $334.43
73552 <1% 13 $307.26
H2000 Comprehensive multidisciplinary evaluation <1% 12 $306.15
J3411 Injection, thiamine hcl, 100 mg <1% 38 $300.02
74000 <1% 31 $290.34
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 162 $288.22
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 57 $278.93
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 182 $277.29
73560 <1% 16 $276.36
J1171 Injection, hydromorphone, 0.1 mg <1% 284 $265.94
J3535 Drug administered through a metered dose inhaler <1% 298 $259.14
88312 <1% 32 $249.94
J1956 Injection, levofloxacin, 250 mg <1% 71 $237.06
J1836 Injection, metronidazole, 10 mg <1% 15 $235.88
A4648 Tissue marker, implantable, any type, each <1% 29 $226.26
73060 <1% 14 $209.40
84153 <1% 13 $180.01
80306 <1% 17 $175.56
99070 <1% 997 $170.27
84450 <1% 63 $161.70
S9452 Nutrition classes, non-physician provider, per session <1% 12 $141.24
J2470 Injection, pantoprazole sodium, 40 mg <1% 139 $139.16
36600 <1% 43 $124.74
82310 <1% 235 $90.72
86780 <1% 17 $89.56
82607 <1% 25 $81.22
0370 <1% 537 $73.45
87899 <1% 40 $72.15
84075 <1% 231 $71.70
0391 <1% 372 $68.20
94664 <1% 131 $63.74
59425 <1% 39 $60.48
87045 <1% 16 $59.47
88300 <1% 50 $59.05
81050 <1% 53 $55.16
29130 <1% 13 $54.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 14,464 $49.78
77062 <1% 468 $49.32
87324 <1% 12 $43.15
87015 <1% 17 $42.68
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 1,386 $38.70
87046 <1% 16 $31.45
87102 <1% 13 $26.81
89051 <1% 28 $24.37
77061 <1% 163 $23.67
84155 <1% 127 $17.75
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 125 $17.51
84466 <1% 27 $11.01
A9270 Non-covered item or service <1% 5,831 $10.33
82077 <1% 44 $8.40
S0074 Injection, cefotetan disodium, 500 mg <1% 14 $7.58
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 17 $7.23
64450 <1% 12 $7.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 64 $4.97
S0028 Injection, famotidine, 20 mg <1% 2,584 $4.95
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 12 $0.68
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 93 $0.01
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 143 $0.01
0331 0% 40 $0.00
0307 0% 387 $0.00
0610 0% 30 $0.00
0636 0% 1,877 $0.00
0310 0% 129 $0.00
G0008 Administration of influenza virus vaccine 0% 56 $0.00
A4913 Miscellaneous dialysis supplies, not otherwise specified 0% 768 $0.00
0335 0% 299 $0.00
0404 0% 38 $0.00
0949 0% 551 $0.00
0401 0% 86 $0.00
97166 0% 55 $0.00
0305 0% 379 $0.00
0372 0% 38 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 12 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 27 $0.00
0922 0% 71 $0.00
80050 General health panel 0% 128 $0.00
0352 0% 218 $0.00
0324 0% 462 $0.00
0306 0% 1,557 $0.00
Q4051 Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) 0% 23 $0.00
0301 0% 5,052 $0.00
0611 0% 13 $0.00
0420 0% 186 $0.00
0612 Calcium glucon (wg critical) 0% 15 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 15 $0.00
0410 0% 56 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 12 $0.00
A4657 Syringe, with or without needle, each 0% 405 $0.00
0300 0% 2,171 $0.00
0361 0% 454 $0.00
0260 0% 340 $0.00
0510 0% 261 $0.00
84112 0% 33 $0.00
0403 0% 94 $0.00
0320 0% 301 $0.00
0351 0% 88 $0.00
0302 0% 191 $0.00
0489 0% 33 $0.00
0634 0% 293 $0.00
0424 0% 23 $0.00
0402 0% 995 $0.00
0349 0% 34 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 21 $0.00
0333 0% 212 $0.00
0762 0% 31 $0.00
0343 0% 15 $0.00
0278 0% 154 $0.00
0390 0% 31 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS)
Same official

Other billing entities under ANDERSON, DONALD

Full network →
ProviderLocationPaid
Providence Health & Services WashingtonAnchorage, AK$161.45M
Kadlec Regional Medical CenterRichland, WA$151.60M
Swedish EdmondsEdmonds, WA$30.06M
ST. Joseph Health Northern California, LLCEureka, CA$28.68M
Providence Health System Southern CaliforniaTorrance, CA$27.29M
Providence Health System - Southern CaliforniaSan Pedro, CA$24.26M
Providence Health & Services - WashingtonTukwila, WA$21.98M
Swedish Health ServicesSeattle, WA$21.06M
Providence Health & Services WashingtonKodiak, AK$11.39M
Swedish Health ServicesSeattle, WA$11.08M
ST. Joseph Health Northern California, LLCFortuna, CA$8.55M
Collabria CareNapa, CA$8.20M
Providence Health & Services OregonSeaside, OR$8.01M
Providence Health & Services- WashingtonSpokane, WA$8.01M
Hospice of Lubbock INCLubbock, TX$6.48M
Providence Saint John's Health CenterSanta Monica, CA$5.52M
Methodist Hospital LevellandLevelland, TX$4.55M
Collabria CareNapa, CA$4.05M
Methodist Hospital LevellandLevelland, TX$4.01M
Methodist Hospital Plainview TexasPlainview, TX$4.00M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.